Skip to main content
. 2021 Sep 21;11:738567. doi: 10.3389/fonc.2021.738567

Figure 4.

Figure 4

(A) Histopathologic examination of the tissues including the heart, liver, spleen, lung, and kidney from tumor-bearing mice after PBS or ZCM treatment. (B) Blood biochemistry data for kidney function marker BUN. (C) Blood biochemistry data including kidney function marker CRE. (D) Liver function markers: ALT, AST, and ALP.